MTHFR C677T polymorphism and cerebrovascular lesions in elderly patients with CSVD: A correlation analysis
Open Access
- 23 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 987519
Abstract
Plasma homocysteine (Hcy) has been identified as a potential risk factor for cerebral small vessel disease. Cerebral small vessel disease (CSVD) leads to cognitive impairment, depression, and other symptoms and is a common disease in middle-aged and elderly people. To investigate the relationship between 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and CSVD in elderly patients, plasma levels of homocysteine (Hcy) and MTHFR genotyping were assessed. MRI and MRA were performed at the same time to analyze the relationship between different genotypes and cerebrovascular lesions. We showed that Hcy plasma levels in the TT group were significantly higher than those in the CC and CT groups. Moreover, we observed that the severity of white matter lesions was associated with women and positively correlated with age, previous coronary heart disease, luminal infarction, and MTHFR polymorphism. The multivariate logistic regression analysis showed that age, TT genotype, and lacunar infarction were independent risk factors for white matter hyperintensity (WMH). Importantly, we showed that there was a significant correlation between Hcy plasma levels and MTHFR gene polymorphism, with the TT genotype constituting an independent risk factor for WMH. Therefore, we recommended early detection of MTHFR gene polymorphisms with concomitant early intervention concerning risk factors to delay the occurrence of cognitive impairment in CSVD elderly patients.Keywords
Funding Information
- Guangzhou Municipal Health and Family Planning Commission
This publication has 20 references indexed in Scilit:
- Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trialsThe Lancet, 2011
- B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trialThe Lancet Neurology, 2010
- Future Cardiovascular Disease in ChinaCirculation: Cardiovascular Quality and Outcomes, 2010
- Homocysteine and Its Relationship to Stroke Subtypes in a UK Black PopulationStroke, 2008
- Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive ConsequencesStroke, 2008
- Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?BMJ, 2005
- Serum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in JapaneseCirculation, 2004
- Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunctionBrain, 2004
- Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?Stroke, 2003
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTStroke, 2001